Literature DB >> 6304881

Herpes simplex virus glycoprotein D: human monoclonal antibody produced by bone marrow cell line.

J M Seigneurin, C Desgranges, D Seigneurin, J Paire, J C Renversez, B Jacquemont, C Micouin.   

Abstract

Normal bone marrow cells from a donor positive for herpes simplex virus were transformed with Epstein-Barr virus. The resulting lymphoblastoid cell line has secreted immunoglobulin G1 of the kappa type continuously for 2 years. This immunoglobulin, detected both on the cell surface and in the cytoplasm, reacts with cells infected with herpes simplex virus. It defines an antigen that comigrates with the 55-kilodalton glycoprotein D of herpes simplex virus type 1 and neutralizes the infectivity of herpes simplex viruses 1 and 2.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6304881     DOI： 10.1126/science.6304881

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  20 in total

1.  Identification of a site on herpes simplex virus type 1 glycoprotein D that is essential for infectivity.

Authors:  M I Muggeridge; W C Wilcox; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

2.  Characterization of a recombinant herpes simplex virus which expresses a glycoprotein D lacking asparagine-linked oligosaccharides.

Authors:  D L Sodora; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Absence of asparagine-linked oligosaccharides from glycoprotein D of herpes simplex virus type 1 results in a structurally altered but biologically active protein.

Authors:  D L Sodora; G H Cohen; M I Muggeridge; R J Eisenberg
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Functional region IV of glycoprotein D from herpes simplex virus modulates glycoprotein binding to the herpesvirus entry mediator.

Authors:  A H Rux; S H Willis; A V Nicola; W Hou; C Peng; H Lou; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

5.  Deletions in herpes simplex virus glycoprotein D define nonessential and essential domains.

Authors:  V Feenstra; M Hodaie; D C Johnson
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

6.  Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.

Authors:  A V Nicola; M Ponce de Leon; R Xu; W Hou; J C Whitbeck; C Krummenacher; R I Montgomery; P G Spear; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Using Antibodies and Mutants To Localize the Presumptive gH/gL Binding Site on Herpes Simplex Virus gD.

Authors:  Doina Atanasiu; Wan Ting Saw; Eric Lazear; J Charles Whitbeck; Tina M Cairns; Huan Lou; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

8.  A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.

Authors:  I Frank; H M Friedman
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D.

Authors:  A V Nicola; S H Willis; N N Naidoo; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 10.  Human monoclonal antibodies.

Authors:  S P Cole; B G Campling; T Atlaw; D Kozbor; J C Roder
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.